Pure Global

TT4 Rapid Quantitative Test - India CDSCO Medical Device Registration

TT4 Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000395_f7be2a23b94672d9325ecac7ce15354b_8f0a5747633ee1bcf3066b094a498545. This device is marketed under the brand name Biotime . The license holder is M/s Vishat Diagnostic Pvt Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
TT4 Rapid Quantitative Test
UID: IMP/IVD/2021/000395_f7be2a23b94672d9325ecac7ce15354b_8f0a5747633ee1bcf3066b094a498545

Brand Name

Biotime

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Biotime Total Thyroxine (Biotime ) Rapid Quantitative Test is intended to quantify the concentration of total thyroxine in human serum or plasma on Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid detection of thyroid gland disease

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing